KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Staar Surgical (STAA) over the last 12 years, with Q3 2025 value amounting to $762000.0.

  • Staar Surgical's Asset Writedowns and Impairment fell 1221.2% to $762000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 5125.55%. This contributed to the annual value of $2.8 million for FY2024, which is 4265.1% down from last year.
  • Per Staar Surgical's latest filing, its Asset Writedowns and Impairment stood at $762000.0 for Q3 2025, which was down 1221.2% from $468000.0 recorded in Q2 2025.
  • Staar Surgical's 5-year Asset Writedowns and Impairment high stood at $3.0 million for Q2 2023, and its period low was $165000.0 during Q4 2021.
  • Over the past 5 years, Staar Surgical's median Asset Writedowns and Impairment value was $574500.0 (recorded in 2021), while the average stood at $772750.0.
  • Per our database at Business Quant, Staar Surgical's Asset Writedowns and Impairment surged by 25878.79% in 2022 and then plummeted by 8564.32% in 2024.
  • Quarter analysis of 5 years shows Staar Surgical's Asset Writedowns and Impairment stood at $557000.0 in 2021, then decreased by 27.65% to $403000.0 in 2022, then skyrocketed by 88.83% to $761000.0 in 2023, then increased by 9.72% to $835000.0 in 2024, then dropped by 8.74% to $762000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $762000.0 for Q3 2025, versus $468000.0 for Q2 2025 and $2.0 million for Q1 2025.